RESEARCH - Characteristics of patients with RA in France: a study of 1109 patients

[Guest guest]

Ann Rheum Dis. 2004 Oct;63(10):1235-40.

Characteristics of patients with rheumatoid arthritis in France: a study

of 1109 patients managed by hospital based rheumatologists.

Sany J, Bourgeois P, Saraux A, Durieux S, Lafuma A, Daures JP, Guillemin

F, Sibilia J.

Hopital Saint Michel, 33 rue Olivier de Serres, 75 015 Paris, France.

stephanie.durieux@...

OBJECTIVE: To describe the characteristics of rheumatoid arthritis in

patients managed by hospital based rheumatologists in France. METHODS:

All public and non-profit private hospitals in France were invited to

participate in a cross sectional study. Clinical data on the day of

inclusion and health resources used for rheumatoid arthritis over the

previous 12 months (treatments, medical devices, physician visits,

examinations, hospital admissions, and other health professional care)

were recorded. RESULTS: 1109 patients from 75 centres located throughout

the country were included (846 female; mean disease duration, 10.6

years; mean age, 56.7 years). Active disease (swollen joint count >/=6,

tender joint count >/=6, and two of: morning stiffness >/=45 min, C

reactive protein >/=20 mg/l, erythrocyte sedimentation rate >28 mm/h)

was observed in 146 patients (13.2%). Mean (SD) DAS(28) was 4.51 (1.55).

Severe extra-articular manifestations were reported in 8.4%. ACR

functional status was: class I, 19%; class II, 28%; class III, 31%;

class IV, 22%. Comorbidity was observed in 44.9% of cases, particularly

chronic pulmonary disease and coronary or peripheral vascular disease.

Average AIMS2-SF dimension scores were between 4.56 and 6.18, and mean

HAQ was 1.32 (0.77). Disease modifying antirheumatic drugs (DMARDs) were

prescribed for 82.1% of the patients. During the previous four weeks,

one DMARD was used in 62.5%, and two or more in 19.5%. Corticosteroids

were prescribed in 72%.

CONCLUSIONS: In a rheumatoid arthritis population managed by hospital

based rheumatologists, the disease was active in 13% and severe in more

than one third of cases.

PMID: 15361378

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve & db=PubMed & list_uids=1\

5361378 & dopt=Abstract

I'll tell you where to go!

Mayo Clinic in Rochester

http://www.mayoclinic.org/rochester

s Hopkins Medicine

http://www.hopkinsmedicine.org